A new article has been published in Scientific Reports on the progress in site-specific cancer mortality in Canada over the last 70 years. Using data from Statistics Canada and the Global Cancer Observatory, Warkentin et al. (2024) found that there has been “a significant reduction in cancer mortality in Canada since site-specific cancer mortality rates peaked Read more about New Article on Progress in Site-Specific Cancer Mortality[…]
Join CanPath for an informative session on accessing CanPath data and biosamples for your research projects! Whether you’re a seasoned researcher or new to the process, our Access Office experts are here to provide insider tips on ensuring your application is successful. The “Access Office Hours” virtual series provides researchers with an opportunity every quarter to ask Read more about CanPath Access Office Hours[…]
Type 2 diabetes (T2D) is a widespread chronic condition with severe consequences, including complications affecting blood vessels and organs, disability, and premature death. Research indicates that depression can significantly raise the risk of developing T2D, potentially through lifestyle and biological factors. Additionally, our modern diet presents a challenge with the increasing consumption of ultra-processed foods Read more about Upcoming CanPath Webinar on Ultra-processed food consumption, depression, and diabetes[…]
Tune in to the Bold Ideas Colloquium Series on Friday March 15th to hear our colleagues, Dr. Donna Turner and Dr. Travis Hrubeniuk give a presentation about the Manitoba Tomorrow Project Cohort.
Research conducted using CanPath data, including Atlantic PATH found that at least one in five lung cancer cases diagnosed are found in people who have never smoked. Our colleague, Dr. Aaron Goodarzi has written a new article on the risks of lung cancer that rural communities face as a result of exposure to radon. Full article: https://troymedia.com/health/cancer-risk-from-radon-gas-is-higher-in-rural-communities/
We are pleased to share that a new publication from the Psychosocial Factors and Cancer Incidence (PSY-CA) consortium have been published in Cancer Epidemiology. Led from the Netherlands by Dr. Lonneke van Tuijl and Dr. Joost Dekker, this study includes 18 cohorts with more than 300,000 participants including Atlantic PATH, the Ontario Health Study and CARTaGENE from CanPath. Our local team members include Mr. Read more about New Publication – Psychosocial factors, health behaviors and risk of cancer incidence[…]
Authors: Maartje Basten, Kuan-Yu Pan, Lonneke A. vanTuijl, Alexander deGraeff, Joost Dekker, Adriaan W.Hoogendoorn, Femke Lamers, Adelita V. Ranchor, Roel Vermeulen, Lützen Portengen, Adri C. Voogd, Jessica Abell, Philip Awadalla, Aartjan T.F. Beekman, Ottar Bjerkeset, Andy Boyd, Yunsong Cui, Philipp Frank, Henrike Galenkamp, Bert Garssen, Sean Hellingman, Martijn Huisman, Anke Huss, Melanie R. Keats, Almar A.L. Read more about Psychosocial factors, health behaviors and risk of cancer incidence: Testing interaction and effect modification in an individual participant data meta-analysis[…]
Are you a student seeking data for your upcoming project? Wondering how to navigate the CanPath access process effectively? Join CanPath Access Office Hours to discover the requirements for successful student-led projects, learn the ins and outs of data access, and get hands-on guidance from our Access Office experts to elevate your research game. This Read more about Attention Students and Trainees: CanPath Access Office Hours[…]
How does our environment (ex. green spaces, walkability, light at night, air pollution) impact our risk of breast, prostate, lung, and colorectal cancers? And, could the information in our blood, combined with details about our health and lifestyle, help predict the risk of developing breast cancer in the future? 🌱🔬 Join us on Monday, January Read more about Upcoming @CanPath Trainee Webinar on the built environment, metabolites and cancer risk[…]
Dr. John Lewis is a Professor in the Department of Oncology at the University of Alberta and the Bird Dogs Chair in Translational Oncology. Dr. Lewis’ research interests include translational prostate cancer research, and the Lewis Lab utilizes real-time intravital imaging of the tumour microenvironment to learn about the critical steps of cancer progression, including the growth of new Read more about Dr. John Lewis at #CCRC2023[…]